首页> 外文期刊>European Journal of General Medicine >THE ASSOCIATION OF HER-2/NEU OVER-EXPRESSION IN RELATION TO P53 NUCLEAR ACCUMULATION, HORMONAL RECCEPTOR STATUS AND COMMON CLINICO-PATHOLOGICAL PROGNOSTIC PARAMETERS IN A SERIES OF EGYPTIAN WOMEN WITH INVASIVE DUCTAL CARCINOMA
【24h】

THE ASSOCIATION OF HER-2/NEU OVER-EXPRESSION IN RELATION TO P53 NUCLEAR ACCUMULATION, HORMONAL RECCEPTOR STATUS AND COMMON CLINICO-PATHOLOGICAL PROGNOSTIC PARAMETERS IN A SERIES OF EGYPTIAN WOMEN WITH INVASIVE DUCTAL CARCINOMA

机译:一系列患有导管癌的埃及妇女中HER-2 / NEU过表达与P53核蓄积,激素受体状态和常见临床病理预测参数的关系

获取原文
       

摘要

Aim: HER2eu protein has garnered a great deal of interest in the popular media. However, it has long been known among pathologists and oncologists for its potential role as a tumor and prognostic marker. This protein exists on the surface of epithelial cells and functions in the normal cell as a receptor for a cellular growth factor. Aim of the study: is to determine the association of HER-2eu and p53 as well as hormonal receptor status with common pathologic parameters in invasive ductal carcinoma of the breast. Methods: Expression of HER-2eu and p53 was examined by immunohistochemistry in samples of breast tissue from 50 patients with invasive ductal carcinoma and their significance for prognosis was analyzed. Results: There was a significant association between HER-2 over-expression and the accumulation of nuclear p53 (p=0.0017), the increased size of tumor (p=0.0115) as well as the high grade tumors (p=0.0001). On the other hand HER-2 over-expression showed an inverse significant association with ER (p=0.0001) and PR status (p=0.0003). Meanwhile there wasn’t any significant association of HER-2 over-expression with the number of the invaded lymph nodes, grade of tumor necrosis or the menopausal status. Conclusion: The study had indicated that Her-2eu may be a powerful predictor of poor prognosis as it’s over-expression was strongly directly correlated with p53 nuclear accumulation, tumor size and grade and inversely correlated with hormonal receptor status of breast carcinoma. Meanwhile; no significant associated for number of invaded lymph nodes and the menopausal status.
机译:目的:HER2 / neu蛋白在流行媒体中引起了极大的兴趣。但是,由于其作为肿瘤和预后标志物的潜在作用,在病理学家和肿瘤学家中早已为人所知。该蛋白质存在于上皮细胞的表面,并在正常细胞中用作细胞生长因子的受体。研究的目的是确定乳腺癌浸润性导管癌中HER-2 / neu和p53以及激素受体状态与常见病理参数之间的关系。方法:采用免疫组织化学方法检测50例浸润性导管癌患者乳腺组织中HER-2 / neu和p53的表达,并分析其对预后的意义。结果:HER-2的过表达与核p53的积累(p = 0.0017),肿瘤大小增加(p = 0.0115)和高级别肿瘤(p = 0.0001)之间存在显着相关性。另一方面,HER-2过度表达与ER(p = 0.0001)和PR状态(p = 0.0003)呈负相关。同时,HER-2的过表达与浸润的淋巴结数目,肿瘤坏死程度或绝经状态没有显着相关性。结论:该研究表明,Her-2 / neu可能是预后不良的有力预测指标,因为其过度表达与p53核蓄积,肿瘤大小和等级密切相关,与乳腺癌的荷尔蒙受体状态呈负相关。与此同时;浸润的淋巴结数目与绝经状态无显着相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号